Flawed Therapy: Hormone replacement takes more hits | Science News


Support Science Journalism

Science News is a nonprofit.

Support us by subscribing now.


Flawed Therapy: Hormone replacement takes more hits

1:20pm, May 28, 2003

Expectations for hormone-replacement therapy for postmenopausal women have turned topsy-turvy in recent years. Initial studies suggesting remarkable benefits from the drugs gave way to reports of little gain. Most recently, the rap sheet on estrogen and progestin includes signs of harm.

The latest bad news for the treatment appears in two articles in the May 28 Journal of the American Medical Association, where scientists report that the hormone combination boosts the risk of dementia and stroke in otherwise healthy women. Another recent report challenges the view that the therapy increases women's feelings of well-being.

The findings all stem from the Women's Health Initiative, a nationwide study that began in the early 1990s and enrolled more than 27,000 women in its hormone-replacement component. In 2002, researchers stopped part of this component, 3 years before its scheduled conclusion, because interim results showed that postmenopausal women taking estrog

This article is only available to Science News subscribers. Already a subscriber? Log in now.
Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content